NEOadjuvant Chemotherapy Only Compared With Standard Treatment for Locally Advanced Rectal Cancer

NCT03280407 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

124

Enrollment

OTHER

Sponsor class

Conditions

Colorectal Neoplasm
Colorectal Cancer
Rectal Neoplasms
Chemotherapy Effect
Intestinal Disease
Intestinal Neoplasms
Rectal Cancer

Interventions

DRUG: Capecitabine
DRUG: FOLFOX regimen (oxaliplatin/leucovorin/5FU)
DRUG: CAPOX (oxaliplatin/capecitabine)

Sponsor

Zealand University Hospital